LaserSurgeryForEyes.com

SRP is an investigational procedure not yet performed in the United States. The Presby Corp. has just received FDA approval to begin preliminary testing. Lasersurgeryforeyes.com is not advocating or endorsing this procedure. We are an information resource providing information on the latest vision correction procedures. Lasersurgeryforeyes.com provides a listing of Laser Vision Correction Surgeons. Some of the surgeons may include SRP in their practice but not all the surgeons in our directory perform this investigational procedure.

Presby Corp is marketing a revolutionary technology in the field of ophthalmology. The company has developed a surgical technique called SRP (Surgical Reversal of Presbyopia), which uses a tiny patented device (the "Scleral Expansion Band" or "SEB") to reverse presbyopia in the human eye.

Presbyopia is the primary reason that nearly everyone after their mid-40's uses bifocals, reading glasses, or removes their distance glasses in order to read at a comfortable distance. Prior to the development of SRP, external lenses such as bifocals and reading glasses were the principal alternatives available to counter the effects of presbyopia. The Company believes that SRP is the only procedure which provides satisfactory restoration of the ability to focus (accommodate) through the physiological reversal of presbyopia.

The Surgical Reversal of Presbyopia (SRP) provides the following benefits to patients:

Long term corrected vision - SRP is designed to restore the human eye in persons in their mid-40's or older to the physiological condition of a much younger eye. The company believes that SRP will benefit the patient for a considerable number of years.
Low Risk Procedure - SRP involves operating on the sclera (white of the eye), a surface of the eye rarely associated with surgical complications.
Minimally invasive procedure - The procedure can be completed by trained physicians using topical and/or local anesthesia in about 30 minutes on an outpatient basis. The patients are able to enjoy improved vision almost immediately after the procedure.
Reversible- Investigational surgeries have demonstrated that the Scleral Expansion Band can be removed and the patient's eye returns to its original preoperative characteristics.
Reduction in intraocular pressure in patients with ocular hypertension and primary open angle glaucoma - Preliminary international clinical data has demonstrated that SRP may be effective in treating hypertension and primary open angle glaucoma.

The company's primary product, the Scleral Expansion Band or "SEB", is injection molded from polymethylmethacrylate (PMMA), the historical standard for ocular biocompatibility. PMMA has been used in intraocular lens implants for nearly fifty years. The injection molding process, biocompatibility testing and sterilization is outsourced to specialists firms. Presby performs product quality control, packaging, marketing and worldwide distribution of the product.

The SEB consists of four separate PMMA segments. Each segment is implanted just below the surface of the sclera well outside the cornea (clear part of the eye). Placement of the SEB does not involve operating on any of the optical components of the eye (cornea or lens). The sclera is a very safe part of the eye and is rarely associated with surgical complications. The procedure is done under local anesthesia with the patient wide-awake. Experienced surgeons can perform the procedure on an outpatient basis in about 30 minutes per eye.

SRP is not a laser procedure. Laser procedures are generally designed to treat entirely different vision imperfections unrelated to presbyopia. Unlike laser and most types of refractive surgery, the Company believes SRP is a fully reversible procedure. The Company believes that these characteristics of safety and full reversibility will greatly enhance patient acceptance and ultimate market penetration. Check our news link for recent developements.